Year To Quarter End Consolidated Statement Of Comprehensive Income

Carna Biosciences, Inc. - Filing #7726593

Concept 2018-01-01 to
2018-03-31
2017-01-01 to
2017-03-31
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-194,481,000 JPY
-118,646,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-311,000 JPY
16,000 JPY
Foreign currency translation adjustment
-3,231,000 JPY
-2,440,000 JPY
Other comprehensive income
-3,543,000 JPY
-2,424,000 JPY
Comprehensive income
-198,024,000 JPY
-121,070,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-198,024,000 JPY
-121,070,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.